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Hyponatremia in children with 
respiratory infections: a cross-
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3938 patients
Sung Won Park 1, Son Moon Shin1, Moonsun Jeong1, Dong-Hee Cho2, Keum Hwa Lee3, 
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Hyponatremia can be a life-threatening illness among hospitalized children. The aims of this study were 
to evaluate the incidence and risk factors of hyponatremia in 3938 children who were admitted to the 
Cheil General Hospital and Women’s Health Care Center with respiratory infections. Clinical data were 
collected, and multiplex RT-PCR analyses were done for various microorganisms. Hyponatremia was 
observed in 531 (13.5%) patients. The incidence of hyponatremia differed according to the respiratory 
tract infection (P < 0.0001) and microorganism (P = 0.001). In children with hyponatremia, the age at 
admission was significantly older (P < 0.0001), male gender was more frequent (P = 0.019), CRP was 
higher (P < 0.0001), and coinfection with multiple organisms was more common (P = 0.001) than in 
children without hyponatremia. In multivariate analyses, an older age at admission (P = 0.006), male 
gender (P = 0.004), and increased CRP (P < 0.0001) were independent risk factors. Sodium levels 
correlated negatively with WBC (P = 0.037), CRP (P < 0.0001), and number of hospital days (P = 0.020). 
The AUC values of age (0.586, P < 0.0001), CRP (0.599, P < 0.0001), and blood urea nitrogen (0.559, 
P < 0.0001) were all significant predictors of hyponatremia. This study is the first to show that the 
incidence of hyponatremia differs according to infecting microorganism and radiological findings.
Hyponatremia is defined as a plasma sodium concentration of less than 135 mEq/L and is one of the most com-
mon electrolyte derangements in both adults and children1. It can result from either a deficit of sodium or an 
excess of free water, and the incidence in a small number of cohorts was estimated as 17–45% of hospitalized 
children2–5.
Acute, severe hyponatremia that develops within 48 hours can result in acute cerebral edema and various 
sequelae, such as headache, lethargy, seizures, and cardiac arrest due to brain stem herniation. Children are more 
vulnerable than adults to those sequelae because the brain/intracranial volume ratio is higher in children than 
in adults6–8. Recent evidence suggests that even mild chronic hyponatremia can be related to subtle neurologic 
defects, such as impairments in balance and attention that can increase the incidence of falls9.
The most probable cause of hyponatremia is thought to be the non-osmotic release of antidiuretic hormone 
(ADH) as a result of various clinical conditions, such as fever, hypovolemia, and respiratory tract infections2,4,10. 
Among patients with respiratory tract infections, pneumonia and bronchiolitis are most commonly associ-
ated with hyponatremia3–5. However, the incidence of hyponatremia according to the etiological involvement 
of various microorganisms has not yet been studied. As a key event in the pathophysiology of hyponatremia 
in patients with respiratory tract infections, a syndrome of inappropriate ADH secretion (SIADH) caused by 
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inflammation has been suggested2,4, but it has not been evaluated or validated in a sufficiently large number of 
children. Furthermore, few epidemiologic data are available on hyponatremia in children, and even less is known 
about hyponatremia in children with respiratory infections. Although hyponatremia is well-known to be asso-
ciated with respiratory infections in children and adults, that connection has not been studied in a systematic 
fashion, and no data indicate whether the type of organism, number of organisms, location of infection, or degree 
of inflammation has any effect on the development of hyponatremia.
Therefore, our aim in this study was to evaluate the incidence of hyponatremia according to the presence of 
various microorganisms and to elucidate whether the degree of inflammation might be associated with the devel-
opment of hyponatremia in a large cohort of children hospitalized with respiratory infections.
Results
The baseline characteristics of the 3938 patients with respiratory tract infections are summarized in Table 1. 
The mean age of the study population was 22.9 ± 21.7 months (range 7 days–168.0 months), and the sample 
contained 2195 males (55.7%) and 1743 females (44.3%). The mean duration of hospital stay was 4.4 ± 1.5 days 
(range 1.0–19.0). The mean age, sex, hospital stay, and C-reactive protein (CRP) levels differed with the radiologic 
findings and causal microorganisms (Supplementary Tables 1–7). The study population consisted of 177 patients 
with upper respiratory tract infections (4.5%), 724 patients with acute bronchiolitis (18.4%), 969 patients with 
acute bronchitis (24.6%), 1978 with interstitial pneumonia (50.2%), and 90 with segmental or lobar pneumonia 
(2.3%). In multiplex RT-PCR analyses for nasopharyngeal aspirates, human adenovirus (HAdV) was isolated in 
137 patients (3.5%), influenza A virus (FLUAV) or influenza B virus (FLUBV) in 107 (2.7%), human parainflu-
enza virus (HPIV) in 297 (7.5%), human metapneumovirus (HMPV) in 199 (5.1%), human respiratory syncytial 
virus (HRSV) in 871 (22.1%), human rhinovirus (HRV) in 172 (4.4%), human bocavirus (HBoV) in 576 (14.6%), 
and no virus was detected in 813 patients (20.6%). Mycoplasma pneumoniae infection was detected in 255 patients 
(6.5%), and coinfection with multiple microorganisms was diagnosed in 511 patients (13.0%).
Hyponatremia was observed in 531 (13.5%) of the 3938 patients, among whom 20 had moderate hypona-
tremia (127–130 mEq/L) (Supplementary Fig. 1). No patient had severe hyponatremia, and two patients had 
hypernatremia (146 and 151 mEq/L). The incidence of hyponatremia differed according to the radiologic findings 
(P < 0.0001) and microorganisms (P = 0.001). The incidence of hyponatremia was highest (44.1%) in children 
with upper respiratory tract infections. It was 10.5% in acute bronchitis, 13.4% in interstitial pneumonia, 16.7% in 
segmental and lobar pneumonia, and lowest (9.7%) in acute bronchiolitis. Upper respiratory infections were over-
represented in the hyponatremia group (14.6% vs 2.9%), whereas acute bronchitis and bronchiolitis were under-
represented in the hyponatremia group. In univariate analyses, children with hyponatremia were significantly older 
(P < 0.0001), more likely to be male (P = 0.019), and had higher CRP levels (P < 0.0001) and coinfections with 
multiple organisms (P = 0.001) than children without hyponatremia. In addition, serum potassium, chloride, total 
Variables Total
Age (months) 22.9 ± 21.7 (range 7 days–168.0 months)
Sex
  Male 2195 (55.7%)
  Female 1743 (44.3%)
Hospital stay (days) 4.4 ± 1.5 (range 1.0–19.0)
Diagnosis
  Upper respiratory infection 177 (4.5%)
  Acute bronchiolitis 724 (18.4%)
  Acute bronchitis 969 (24.6%)
  Interstitial pneumonia 1978 (50.2%)
  Segmental or lobar pneumonia 90 (2.3%)
Etiologies
  HAdV 137 (3.5%)
  FLUAV or FLUBV 107 (2.7%)
  HPIV 297 (7.5%)
  HMPV 199 (5.1%)
  HRSV 871 (22.1%)
  HRV 172 (4.4)
  HBoV 576 (14.6%)
  No virus detected 813 (20.6%)
  Mycoplasma pneumoniae 255 (6.5%)
  Coinfection† 511 (13.0%)
Table 1. Baseline characteristics of the 3938 patients with respiratory infections. HAdV: Human adenovirus, 
FLUAV/FLUBV: Influenza virus A/B, HPIV: Human parainfluenza virus, HMPV: Human metapneumovirus, 
HRSV: Human respiratory syncytial virus, HRV: Human rhinovirus, HBoV: Human bocavirus. †Coinfection 
describes patients who tested positive for more than two microorganisms.
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carbon dioxide (tCO2), calcium, and phosphorus levels were significantly lower, and serum blood urea nitrogen 
(BUN) levels were significantly higher in children with hyponatremia than in those without it (Table 2).
Patients infected by 2 or 3 organisms had a higher incidence of hyponatremia then those with a monoinfec-
tion. In the hyponatremia group, the detection of two microorganisms was more common (P = 0.004), along 
with coinfections in general (p = 0.001), than in the without-hyponatremia group. HAdV was the only organism 
overrepresented in the hyponatremia group (5.3% vs 3.2%). (Table 3).
In multivariate analyses, an older age at admission (OR 1.007, 95% CI 1.002–1.012, p = 0.006), male gender 
(OR 1.361, 95% CI 1.105–1.675, p = 0.004), and increased CRP levels (OR 1.093, 95% CI 1.060–1.128, P < 0.0001) 
were independent risk factors for the development of hyponatremia. Coinfection (OR 3.493, 95% CI 0.814–
14.998, P = 0.092) had borderline significance (Table 4). In a comparison of electrolyte changes among patients 
(Table 5), serum sodium (P < 0.0001), chloride (P < 0.0001), and tCO2 levels (P < 0.0001) were increased in both 
groups (with and without hyponatremia) at discharge. The mean sodium level in patients with hyponatremia 
increased from 132.8 mmol/L to 136.9 mmol/L after treatment.
Serum sodium levels correlated positively with serum chloride (r = 0.487, P < 0.0001) and tCO2 levels 
(r = 0.231, P < 0.0001) and negatively with white blood cell (WBC) counts (r = −0.033, P = 0.037) and CRP levels 
(r = −0.130, P < 0.0001). CRP increased the odds ratio of hyponatremia by a small amount (OR 1.093). Also, we 
found an inverse correlation between serum sodium levels and the length of hospital stay (r = −0.037, P = 0.020). 
However, that correlation differed according to the various microorganisms and radiologic findings (Table 6, 
Supplementary Table 8).
The area under the curve (AUC) values of age, CRP, and BUN for the prediction of hyponatremia are described 
in Table 7 and Supplementary Fig. 2. The AUC value of age (0.586, P < 0.0001, 95% CI: 0.559–0.613), CRP (0.599, 
P < 0.0001, 95% CI: 0.571–0.628), and BUN (0.559, P < 0.0001, 95% CI: 0.531–0.588) were all significant pre-
dictors of hyponatremia. The sensitivity, specificity, positive predictive value, negative predictive value, positive 
Variables
Total number of patients (n = 3938)
With hyponatremia 
(n = 531)
Without hyponatremia 
(n = 3407) P value
Age (years) 2.2 ± 1.7 1.9 ± 1.8 <0.0001
Age (months) 26.4 ± 20.8 22.3 ± 21.8 <0.0001
Sex (M/F) 321/210 1,874/1,533 0.019
Hospital stay (days) 4.5 ± 1.5 4.3 ± 1.5 0.093
Diagnosis
  Upper respiratory infection 78 (14.6%) 99(2.9%) <0.0001
  Acute bronchiolitis 70 (13.1%) 654(19.1%) 0.001
  Acute bronchitis 102 (19.2%) 867(25.4%) 0.002
  Interstitial pneumonia 266 (50.0%) 1712(50.2%) 0.947
  Segmental or lobar pneumonia 15 (2.8%) 75(2.2%) 0.371
Laboratory findings at admission
  WBC (/μL) 10,543.3 ± 4,769.6 10,192.0 ± 4,227.5 0.110
  CRP (mg/dL) 2.8 ± 3.7 1.8 ± 2.7 <0.0001
  Na (mmol/L) 133.2 ± 1.2 137.4 ± 1.7 <0.0001
  K (mmol/L) 4.3 ± 0.6 4.4 ± 0.6 0.003
  Cl (mmol/L) 100.8 ± 2.5 103.4 ± 2.4 <0.0001
  tCO2 (mmol/L) 19.7 ± 3.1 21.2 ± 2.8 <0.0001
  Ca (mg/dL) 9.2 ± 0.5 9.5 ± 0.5 <0.0001
  P (mg/dL) 4.7 ± 1.0 5.1 ± 0.9 <0.0001
  ALP (IU/L) 190.2 ± 176.8 191.4 ± 159.0 0.072
  AST (IU/L) 46.7 ± 49.0 42.4 ± 31.0 0.050
  ALT (IU/L) 24.5 ± 37.5 22.6 ± 33.9 0.258
  BUN (mg/dL) 9.6 ± 3.7 8.7 ± 3.4 <0.0001
  Creatinine (mg/dL) 0.339 ± 0.082 0.337 ± 0.080 0.618
Laboratory findings at discharge
  Na (mmol/L) 136.9 ± 2.4 138.5 ± 2.1 <0.0001
  K (mmol/L) 4.2 ± 0.6 4.5 ± 0.6 <0.0001
  Cl (mmol/L) 103.2 ± 2.7 104.0 ± 2.5 0.007
  tCO2 (mmol/L) 21.6 ± 2.7 22.2 ± 2.5 0.057
Coinfection 93 (17.5%) 418 (12.3%) 0.001
Table 2. Comparison of demographic data, diagnosis, and laboratory findings of patients with and without 
hyponatremia. WBC: White blood cell, CRP: C-reactive protein, Na: Sodium, K: Potassium, Cl: Chloride, 
tCO2: Total carbon dioxide, Ca: Calcium, P: Phosphorus, ALP: Alkaline phosphatase, AST: Aspartate 
aminotransferase, ALT: Alanine aminotransferase, BUN: Blood urea nitrogen.
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Microorganisms
Total number of patients (n = 3938)
With hyponatremia 
(n = 531)
Without hyponatremia 
(n = 3407) P value
No virus detected 114 (21.5%) 699 (20.5%) 0.614
One microorganism 324 (61.0%) 2290 (67.2%) 0.005
  HAdV 28 (5.3%) 109 (3.2%) 0.011
  FLUAV or FLUBV 13 (2.4%) 94 (2.8%) 0.682
  HPIV 41 (7.7%) 256 (7.5%) 0.866
  HMPV 29 (5.5%) 170 (5.0%) 0.644
  HRSV 108 (20.3%) 763 (22.4%) 0.288
  HRV 22 (4.1%) 150 (4.4%) 0.763
  HBoV 63 (11.9%) 513 (15.0%) 0.053
  Myco 20 (3.8%) 235 (6.9%) 0.011
Two microorganisms 84 (15.8%) 390 (11.4%) 0.004
  HAdV + FLUAV/FLUBV 3 (0.5%) 1 (0.03%) 0.009
  HAdV + HPIV 1 (0.2%) 17 (0.5%) 0.497
  HAdV + HMPV 1 (0.2%) 4 (0.1%) 0.552
  HAdV + HRSV 3 (0.5%) 27 (0.8%) 0.789
  HAdV + HRV 9 (1.8%) 23 (0.7%) 0.015
  HAdV + Myco 8 (1.5%) 20 (0.6%) 0.019
  FLUAV/FLUBV + HPIV 0 (0.0%) 3 (0.1%) 1.000
  FLUAV/FLUBV + HMPV 0 (0.0%) 3 (0.1%) 1.000
  FLUAV/FLUBV + HRSV 7 (1.3%) 21 (0.6%) 0.073
  FLUAV/FLUBV + HRV 3 (0.5%) 2 (0.06%) 0.020
  FLUAV/FLUBV + Myco 6 (1.2%) 28 (0.9%) 0.475
  HPIV + HMPV 2 (0.4%) 4 (0.1%) 0.188
  HPIV + HRSV 0 (0.0%) 10 (0.3%) 0.376
  HPIV + HRV 4 (0.8%) 20 (0.6%) 0.555
  HPIV + Myco 7 (1.3%) 29 (0.9%) 0.293
  HMPV + HRSV 0 (0.0%) 7 (0.2%) 0.604
  HMPV + HRV 1 (0.2%) 2 (0.06%) 0.353
  HMPV + Myco 8 (1.5%) 21 (0.6%) 0.026
  HMPV + HBoV 0 (0.0%) 1 (0.03%) 1.000
  HRSV + HRV 3 (0.5%) 42 (1.2%) 0.269
  HRSV + Myco 11 (2.1%) 79 (2.3%) 0.723
  HRV + Myco 7 (1.3%) 26 (0.7%) 0.192
Three microorganisms 8 (1.5%) 28 (0.9%) 0.123
  HAdV + FLUAV/FLUBV + HRSV 0 (0.0%) 1 (0.03%) 1.000
  HAdV + HPIV + HMPV 0 (0.0%) 1 (0.03%) 1.000
  HAdV + HPIV + HRV 1 (0.2%) 1 (0.03%) 0.252
  HAdV + HPIV + Myco 2 (0.4%) 1 (0.03%) 0.050
  HAdV + HPIV + HRSV 1 (0.2%) 0 (0.0%) 0.135
  HAdV + HMPV + HRSV 0 (0.0%) 1 (0.03%) 1.000
  HAdV + HRSV + HRV 0 (0.0%) 1 (0.03%) 1.000
  HAdV + HRSV + Myco 3 (0.5%) 5 (0.2%) 0.081
  HAdV + HRV + Myco 0 (0.0%) 2 (0.06%) 1.000
  FLUAV/FLUBV + HRSV + HRV 0 (0.0%) 1 (0.03%) 1.000
  FLUAV/FLUBV + HRSV + Myco 0 (0.0%) 1 (0.03%) 1.000
  FLUAV/FLUBV + HRV + Myco 0 (0.0%) 1 (0.03%) 1.000
  HPIV + HRSV + HRV 0 (0.0%) 1 (0.03%) 1.000
  HPIV + HRV + Myco 1 (0.2%) 5 (0.2%) 0.581
  HMPV + HRSV + Myco 0 (0.0%) 1 (0.03%) 1.000
  HMPV + HSV + Myco 0 (0.0%) 1 (0.03%) 1.000
  HRSV + HRV + Myco 0(0.0%) 4(0.1%) 1.000
Four microorganisms 1 (0.2%) 0 (0.0%) 0.135
  HAdV + HPIV + HRV + Myco 1 (0.2%) 0 (0.0%) 0.135
Coinfection total† 93 (17.5%) 418 (12.3%) 0.001
Table 3. Etiology of 3938 patients with and without hyponatremia. HAdV: Human adenovirus, FLUAV/
FLUBV: Influenza virus A/B, HPIV: Human parainfluenza virus, HMPV: Human metapneumovirus, HRSV: 
Human respiratory syncytial virus, HRV: Human rhinovirus, HBoV: Human bocavirus, Myco: Mycoplasma 
pneumoniae. †Coinfection describes patients who tested positive for more than two microorganisms.
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likelihood ratio, and negative likelihood ratio of age, CRP, and BUN were determined with different cut-off values. 
The sensitivity and specificity of age (cut-off value of 18.0 months), CRP (cut-off value of 0.5 mg/dL), and BUN 
(cut-off value of 9.0 mg/dL) were 57.44% and 55.88%, 60.22% and 52.98%, and 51.32% and 56.05%, respectively 
(Table 8).
Variables
Odds 
ratio 95% CI P value
Age (months) 1.007 1.002–1.012 0.006
Sex (male) 1.361 1.105–1.675 0.004
CRP 1.093 1.060–1.128 <0.0001
Coinfection† 3.493 0.814–14.998 0.092
WBC 1.003 0.979–1.027 0.826
Hospital stay (days) 1.014 0.942–1.091 0.715
Table 4. Multiple logistic regression analyses of laboratory parameters associated with the development of 
hyponatremia in children with respiratory infections. CI: Confidence interval, CRP: C-reactive protein.
Group Laboratory 
findings
Total number of patients
P value
Without hyponatremia
P value
With hyponatremia
P value
(n = 353) (n = 531) (n = 119) (n = 3407) (n = 234)
At admission 
Mean ± SD
At discharge 
Mean ± SD
At admission 
Mean ± SD
At admission 
Mean ± SD
At discharge 
Mean ± SD
At 
admission
Na (mmol/L) 135.5 ± 2.4 137.9 ± 2.3 <0.0001 132.8 ± 1.4 136.9 ± 2.4 <0.0001 136.9 ± 1.5 138.5 ± 2.1 <0.0001
K (mmol/L) 4.4 ± 0.6 4.4 ± 0.6 0.732 4.3 ± 0.6 4.2 ± 0.6 0.094 4.4 ±± 0.6 4.5 ± 0.6 0.112
Cl (mmol/L) 102.0 ± 2.5 103.7 ± 2.6 <0.0001 100.1 ± 2.3 103.2 ± 2.7 <0.0001 103.0 ± 2.0 104.0 ± 2.5 <0.0001
tCO2 (mmol/L) 20.1 ± 2.9 22.0 ± 2.6 <0.0001 19.1 ± 3.1 21.6 ± 2.7 <0.0001 20.7 ± 2.7 22.2 ± 2.5 <0.0001
Table 5. Comparison of electrolyte changes between patients with and without hyponatremia. SD: Standard 
deviation, Na: Sodium, K: Potassium, Cl: Chloride, tCO2: Total carbon dioxide.
Valuables
Na and CRP Na and hospital stay Na and WBC
r P value r P value r P value
Sex
Male (−) 0.147 <0.0001 (−) 0.046 0.030 (−) 0.020 0.355
Female (−) 0.125 <0.0001 (−) 0.026 0.270 (−) 0.050 0.036
Total patients (−) 0.130 <0.0001 (−) 0.037 0.020 (−) 0.033 0.037
Diagnosis
Acute respiratory infection (−) 0.146 0.067 (−) 0.069 0.358 (−) 0.080 0.292
Acute bronchiolitis (−) 0.006 0.884 0.013 0.736 0.030 0.421
Acute bronchitis (−) 0.106 0.002 (−) 0.026 0.416 0.029 0.372
Interstitial pneumonia (−) 0.119 <0.0001 (−) 0.068 0.002 (−) 0.041 0.067
Segmental or lobar 
pneumonia (−) 0.052 0.643 (−) 0.138 0.194 (−) 0.170 0.110
Microorganisms
No virus (−) 0.114 0.001 (−) 0.079 0.024 (−) 0.059 0.095
HAdV (−) 0.086 0.312 (−) 0.044 0.602 (−) 0.044 0.602
FLUAV or FLUBV 0.073 0.456 0.033 0.739 0.059 0.545
HPIV (−) 0.093 0.108 (−) 0.027 0.642 (−) 0.058 0.334
HMPV (−) 0.108 0.126 (−) 0.078 0.272 0.000 0.997
HRSV (−) 0.116 0.001 0.021 0.526 (−) 0.002 0.950
HRV (−) 0.317 <0.0001 (−) 0.096 0.208 0.156 0.040
HBoV (−) 0.004 0.982 (−) 0.113 0.007 0.015 0.714
Myco (−) 0.001 0.991 0.010 0.870 (−) 0.028 0.651
Coinfection† (−) 0.130 <0.0001 (−) 0.037 0.020 (−) 0.033 0.037
Table 6. Correlations among serum sodium, CRP, and duration of hospitalization. Na: Sodium, Hosp: 
Hospital stay (day), WBC: White blood cell, CRP: C-reactive protein, HAdV: Human adenovirus, FLUAV/
FLUBV: Influenza virus A/B, HPIV: Human parainfluenza virus, HMPV: Human metapneumovirus, HRSV: 
Human respiratory syncytial virus, HRV: Human rhinovirus, HBoV: Human bocavirus, Myco: Mycoplasma 
pneumonia, (−): Negative correlation. †Coinfection describes patients who tested positive for more than two 
microorganisms.
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Discussion
Hyponatremia is the most commonly encountered finding in both adults and children with respiratory tract 
infections. Since Stormont and Waterhouse first reported the association of hyponatremia with pneumonia in 
196211, only case reports and a few relevant studies have been published about this relationship in children3–5,12.
The incidence of hyponatremia has been reported to be about 30% in a small number of children with pneu-
monia or acute HRSV bronchiolitis3–5, but it has not been estimated in children hospitalized with acute tonsillo-
pharyngitis or acute bronchitis. Moreover, no report has considered the incidence of hyponatremia in children 
with respiratory tract infections according to the viral etiology, such as adenovirus, metapneumovirus, parainflu-
enza virus, and rhinovirus. Our study population was the first and largest cohort in the literature evaluating the 
incidence of hyponatremia in children with respiratory tract infections according to the causal microorganisms 
or radiologic findings. We found an overall incidence of hyponatremia (<135 mEq/L) of 531 from among 3938 
patients (13.5%), and we found no cases with a sodium level of less than 126 mEq/L or seizures. Although a pre-
vious small cohort suggested that there was no association between hyponatremia and etiology or radiological 
patterns in pneumonia3, we found that the incidence of hyponatremia was highest (20.7%) in children with ade-
novirus infection and lowest (7.8%) in those with mycoplasma infection. Although adenovirus was not the most 
common cause of infection, it was the leading cause of hyponatremia. It may be because the adenovirus infection 
has a more intenstive systemic inflammatory response as reflected in a greater CRP elevation and more fever than 
other respiratory viral infections. (Supplementary Table 7).
We also found that the incidence of hyponatremia was highest (44.1%) in children with acute tonsillopharyn-
gitis with no chest X-ray abnormalities, in contrast to the results of the small cohort described by Kaneko et al.12. 
They found that deeper inflammatory sites in the respiratory tract were associated with a higher prevalence of 
hyponatremia in children with respiratory tract infections (pharyngitis 13.3%, bronchitis or bronchiolitis 22.9%, 
and pneumonia 38.7%). In our study, the WBC and CRP levels in children with acute tonsillopharyngitis were 
higher than they were in the other groups, and we speculate that the degree of inflammation rather than the 
inflammatory site might be involved in the development of hyponatremia.
Although the mechanism underlying the development of hyponatremia in respiratory infections is elusive, 
the traditional concept has been SIADH, in which fever or dehydration reset the osmostat for ADH secretion 
or increase atrial natriuretic peptide13. According to a previous study, SIADH occurs frequently among children 
hospitalized with pneumonia; Singhi and Dhawan et al.4 found that 68% of hyponatremia in community acquired 
pneumonia had characteristics typical of SIADH4,14.
There have been studies that hyponatremia is associated with CRP in various diseases15–17. Now, we sug-
gest that in patients with respiratory tract infections, SIADH could be caused by the inflammation itself. Recent 
research revealed that inflammatory cytokines such as interleukin (IL)−1β and IL-6 are involved in the develop-
ment of hyponatremia associated with inflammatory conditions, and they might be related to ADH secretion18–20. 
Landgraf et al.21 reported that IL-1β stimulated both the central and peripheral release of vasopressin in rats. In 
addition, Palin et al.22 suggested that IL-6 induces activation of arginine vasopressin (AVP) neurons in response 
to a lipopolysaccharide injection. Most notably, Mastorakos et al.23 demonstrated that AVP levels were elevated 
Valuables AUC Standard error *P Value 95% CI
Age (months) 0.586 0.014 <0.0001 0.559–0.613
CRP (mg/dL) 0.599 0.014 <0.0001 0.571–0.628
BUN (mg/dL) 0.559 0.014 <0.0001 0.531–0.588
Table 7. AUC values of age, CRP, and BUN for the prediction of hyponatremia. AUC: Area under the curve, 
CI: Confidence interval, CRP: C-reactive protein, BUN: Blood urea nitrogen. *P values are based on the null 
hypothesis that AUC = 0.5.
Sensitivity  
(95% CI)
Specificity  
(95% CI)
Positive 
predictive value
Negative 
predictive value
Positive 
LR Negative LR
Age (months)
>6.0 83.24 (79.8–86.3) 24.77 (23.3–26.3) 10.9 93.0 1.10 0.68
>12.0 76.27 (72.4–79.8) 38.98 (37.3–40.6) 12.2 93.7 1.25 0.61
>18.0 57.44 (53.1–61.7) 55.88 (54.2–57.6) 12.6 92.2 1.30 0.76
CRP (mg/dL)
>0.1 85.16 (81.6–88.3) 22.53 (21.0–24.1) 10.9 93.2 1.10 0.66
>0.4 70.75 (66.4–74.9) 42.08 (40.3–43.9) 12.0 92.8 1.22 0.70
>0.7 60.22 (55.6–64.7) 52.98 (51.2–54.8) 12.5 92.3 1.28 0.75
BUN (mg/dL)
>6.0 82.83 (79.3–85.9) 22.12 (20.7–23.6) 10.6 92.1 1.06 0.78
>7.0 74.72 (70.8–78.4) 32.08 (30.5–33.7) 10.9 91.9 1.10 0.79
>9.0 51.32 (47.0–55.7) 56.05 (54.4–57.7) 11.5 91.2 1.17 0.87
Table 8. Diagnostic accuracy of age, CRP, and BUN for the prediction of hyponatremia. CRP: C-reactive 
protein, BUN: Blood urea nitrogen, CI: Confidence interval, LR: Likelihood ratio.
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2 hours after IL-6 injection in six patients. They suggested that IL-6 activated magnocellular AVP-secreting neu-
rons and that it might be involved in the development of inappropriate AVP secretion. Previously, two small stud-
ies on pneumonia showed an inverse relationship between inflammatory markers and serum sodium levels3,24. In 
our large cohort, we demonstrated that serum sodium levels were inversely associated with the degree of inflam-
mation (as demonstrated by WBC and CRP levels) in children with various respiratory tract infections, and our 
logistic regression analysis found that those levels independently predicted the development of hyponatremia. 
CRP is produced in hepatocytes in response to IL-6.
Very few reports have considered the factors that influence serum sodium levels in children with respira-
tory tract infections. No one has previously reported the effect of coinfection on the degree of hyponatremia in 
children with respiratory tract infections; we newly found that coinfection was more frequent in children with 
hyponatremia than in those without it. Although one study showed no gender difference in serum sodium levels 
at admission25, in our large cohort, males were more prone than females to develop hyponatremia. Wrotek et 
al.24 reported that children aged > 4 years with both pneumonia and hyponatremia had higher WBC counts than 
those without hyponatremia, and we found that the age at admission was significantly higher in children with 
hyponatremia. Several studies using small cohorts have suggested that the degree of hyponatremia is inversely 
associated with the length of hospitalization, and we confirmed that finding in our large cohort. Furthermore, we 
are the first to demonstrate, using multiple logistic regression analyses, that among children hospitalized with var-
ious respiratory tract infections, an older age, being male, coinfection, and increased CRP levels are independent 
risk factors for the development of hyponatremia.
Moderate to severe hyponatremia seems to be substantially more common in developing tropical countries 
than elsewhere. For example, the 27–31% of Indian children admitted with both community acquired pneumonia 
and hyponatremia had more severe disease, less favorable outcomes, longer hospitalizations, higher occurrence 
of complications, and higher mortality rates than those admitted with pneumonia but without hyponatremia4. 
However, we found no adverse effects of hyponatremia on patient outcomes because the patients in our cohort had 
mild hyponatremia in most cases, and all patients were discharged from the hospital without any complications.
A recent issue in the treatment of hyponatremia has been the tonicity of maintenance intravenous fluids 
during hospitalization26–29. In our study, we used hypotonic intravenous fluids with and without added sodium 
for hyponatremic and normonatremic patients, respectively. No patient in our cohort experienced aggravation 
of hyponatremia or seizures, but serum sodium levels stayed the same or were only partially corrected in some 
patients, suggesting that those patients might have had SIADH, which requires fluid restriction and the use of iso-
tonic fluids. Recent randomized controlled studies and meta analyses have shown that isotonic intravenous fluids 
reduce the risk of hyponatremia without causing hypernatremia, compared to hypotonic intravenous fluids27,28. 
However, no previous studies have specifically investigated the development of hyponatremia after the use of 
isotonic vs. hypotonic fluids in children with respiratory tract infections; this subject thus requires further study.
Guppy et al. suggested that giving increased fluids to patients with respiratory tract infections, traditionally 
recommended by doctors, might cause harm because increased ADH secretion could lead to hyponatremia and 
fluid overload30. However, several experts disagreed with that opinion31,32, arguing that dehydrated patients with 
upper respiratory tract infections or bronchitis should be treated by hydration. Furthermore, the two prospective 
prevalence studies by Guppy et al.4,33 were on children with moderate to severe pneumonia and no clinical signs 
of dehydration. Therefore, doctors need to evaluate the clinical status of children with respiratory tract infections, 
such as oral intake, urine output, and signs of dehydration, before selecting appropriate maintenance intravenous 
fluids. Nevertheless, because isotonic intravenous fluids are more compatible for correcting dehydration and 
its related ADH secretion, we recommend the use of isotonic fluids at admission, and the infusion rate can be 
adjusted according to the status of the patients.
The main limitation of this study is that this study is a retrospective study and therefore it is difficult to pre-
cisely assess the severity of the disease and correlation with hyponatremia because it is judged by the investigation 
of records.
In conclusion, we are the first to evaluate the incidence of hyponatremia according to various microorganisms, 
along with the factors that affect the development of hyponatremia in a large cohort of children hospitalized with 
respiratory tract infections. Understanding those characteristics provide insight for clinicians as they choose 
appropriate maintenance intravenous fluids. Furthermore, our results provide important clues for unraveling the 
mechanisms of hyponatremia in children hospitalized with respiratory tract infections.
Methods
Subjects. We enrolled and retrospectively analyzed data from 3938 children who were admitted to the Cheil 
General Hospital and Women’s Healthcare Center at the Dankook University College of Medicine for various 
respiratory tract infections between March, 2011, and February, 2014. This study design and the use of patient 
information stored in the hospital database were approved by the Institutional Review Board and the research 
ethics committee of Cheil General Hospital and Women’s Health Care Center. We were given an exemption from 
the requirement for informed consent because our study was retrospective, personal identifiers were completely 
removed, and the data were analyzed anonymously. Our study was conducted according to the ethical standards 
laid down in the 1964 Declaration of Helsinki and its later amendments.
Laboratory and radiologic investigations. Clinical data such as age, sex, and duration of hospitalization 
were collected. Laboratory data acquired at admission included complete blood cell counts, the erythrocyte sed-
imentation rate, CRP, serum electrolytes (sodium, potassium, chloride, and tCO2), renal function testing (BUN 
and creatinine), and liver function testing (aspartate transaminase, alanine transaminase, and alkaline phos-
phatase). Follow-up electrolyte examinations were carried out in cases with abnormal electrolytes at admission. 
A chest X-ray was performed in all patients and was interpreted by a pediatric radiologist.
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Definitions. Hyponatremia was defined as a serum sodium concentration (Na+) <135 mEq/L. Serum 
sodium levels were analyzed using a blood test on admission.
The patients were classified into 5 disease categories according to their symptoms and chest X-ray findings.
 1. Upper respiratory tract infection: It is defined as an acute infection which involves the upper respiratory 
tract including the nose, sinuses, pharynx or larynx. We defined upper respiratory infection as diseases 
including nasal obstruction, sore throat, tonsillitis, pharyngitis, laryngitis, sinusitis, otitis media, and the 
common cold but the chest X-ray showed normal findings34.
 2. Acute bronchiolitis: The diagnosis of acute bronchiolitis is typically made by clinical examination35. The 
bronchiolitis is blockage of the small airway in the lungs due to a viral infection It usually only occurs in 
children less than two years of age36. We defined acute bronchiolitis as a disease in which an infant under 
two years of age develops cough, wheeze, and shortness of breath over one or two days and the chest X-ray 
showed peribronchial thickening with or without hyperaeration.
 3. Acute bronchitis: Bronchitis is inflammation of the bronchi (large and medium-sized airways) in the lungs. 
Symptoms include coughing up mucus, wheezing, shortness of breath, and chest discomfort37. We defined 
bronchitis as when patients have symptoms of bronchitis and the chest X-ray signs having bronchial 
wall thickening with increased bronchovascular markings, enlarged vessels without parenchymal lung 
infection.
 4. Interstitial pneumonia: the chest X-ray showed involvement of the areas between the alveoli. Interstitial 
pneumonia involves the areas in between the alveoli.
 5. Segmental or lobar pneumonia: It was defined when the chest X-ray showed the involvement of a single 
lobe or segment of the lung.
Multiplex RT-PCR analysis of nasopharyngeal aspirates and the detection of mycoplasma. 
Strict quality control procedures are used in our hospital. Nasopharyngeal aspirates were collected from patients 
with respiratory infections using a mucus trap with a sterile suction catheter at admission, and samples were 
stored at 4 °C on site before testing. Ribonucleic acid (RNA) extraction from clinical samples was performed from 
the nasopharyngeal aspirates using the Viral Gene-spin TM Viral DNA/RNA Extraction Kit (iNtRON, Seoul, 
South Korea), and cDNAs were synthesized.
To isolate viral nucleic acids, 200 μl of each respiratory sample was used. Reverse transcription was performed 
using the Revert Aid TM First Strand cDNA Synthesis Kit (Fermentas, Ontario, Canada). For viral detection, PCR 
amplification was performed using the Anyplex™ II RV16 Detection Kit (Seegene) with a PTC200 PCR system 
(MJ Research, Alameda, CA, USA) according to the manufacturer’s instructions.
The kit enabled simultaneous detection of FLUAV, FLUBV, HRSV A and B, HAdV, HMPV, human coronavirus 
229 E, human coronavirus NL63, human coronavirus OC43, HPIV −1, −2, −3, −4, HRV A/B/C, and HBoV. 
Reactions are duplicated in two panels (A and B) for detection of the 16 viruses. PCR was assessed after 15 min-
utes at 95 °C for transcriptase reverse enzyme inactivation; 50 cycles at 95 °C for 30 seconds, 60 °C for 60 seconds, 
and 72 °C for 30 seconds; and 1 additional cycle of 55 °C for 30 seconds for completion. The fluorescence was 
detected with a melting curve step, 55 °C–85 °C (5 seconds/0.5 °C).
Mycoplasma pneumoniae infection was detected by Chorus Trio (DIESSE Diagnostica) with a reagent of 
Chorus M. pneumoniae IgM. The reagent is a cartridge that contains 8 compartments. Each compartment con-
tains conjugate, diluted solution, and 3, 3′, 5, 5′ - tetramethyl benzidine. When mounted, 50 μL of serum placed 
in the first compartment can produce results after 30 minutes. The absorbance is expressed as IgM antibody titer 
in patient samples, with an index divided by the absorbance value of the correction material. If the index is less 
than 0.9, the patient is deemed to be negative; if it is 0.9 to 1.1 the patient is deemed ambiguous, and an index of 
more than 1.1 is positive.
Statistical analysis. Statistical analysis was performed using SPSS version 20.0 (SPSS, Inc., USA). 
Continuous variables in two groups were compared using the independent t-test, and if more than 3 groups were 
compared, we used the analysis of variance. Continuous variables are expressed as the mean ± standard devia-
tion. Categorical variables were analyzed by the chi-square test or Fisher’s exact test. Pearson correlation analysis 
was performed to examine the relationship between two continuous variables, and multiple logistic regression 
analyses were performed to find independent predictive factors. In the logistic regression analysis, the CRP was 
used as a continuous variable, not as normal or abnormal. A P value of less than 0.05 was considered statistically 
significant.
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